Stevenson Mark 4

4 · THERMO FISHER SCIENTIFIC INC. · Filed Dec 3, 2021

Insider Transaction Report

Form 4
Period: 2021-12-01
Stevenson Mark P
Executive Vice President
Transactions
  • Sale

    Common Stock

    2021-12-01$636.76/sh1,307$832,24559,256 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-12-0112,3750 total
    Exercise: $157.68Exp: 2024-02-28Common Stock (12,375 underlying)
  • Exercise/Conversion

    Common Stock

    2021-12-01$157.68/sh+12,375$1,951,29086,181 total
  • Sale

    Common Stock

    2021-12-01$629.55/sh2,393$1,506,51378,666 total
  • Sale

    Common Stock

    2021-12-01$630.70/sh2,759$1,740,10175,907 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-12-0114,5500 total
    Exercise: $190.59From: 2021-03-07Exp: 2024-09-07Common Stock (14,550 underlying)
  • Sale

    Common Stock

    2021-12-01$634.82/sh1,204$764,32363,917 total
  • Exercise/Conversion

    Common Stock

    2021-12-01$190.59/sh+14,550$2,773,08573,806 total
  • Sale

    Common Stock

    2021-12-01$627.46/sh1,364$855,85583,409 total
  • Sale

    Common Stock

    2021-12-01$632.79/sh4,317$2,731,75466,859 total
  • Sale

    Common Stock

    2021-12-01$635.96/sh3,354$2,133,01060,563 total
  • Sale

    Common Stock

    2021-12-01$626.54/sh1,408$882,16884,773 total
  • Sale

    Common Stock

    2021-12-01$628.50/sh2,350$1,476,97581,059 total
  • Sale

    Common Stock

    2021-12-01$633.67/sh1,738$1,101,31865,121 total
  • Sale

    Common Stock

    2021-12-01$631.80/sh4,731$2,989,04671,176 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    477.4
  • Common Stock

    (indirect: By Trust)
    5,320
  • Common Stock

    (indirect: By Trust)
    5,320
  • Common Stock

    (indirect: By Trust)
    5,320
  • Common Stock

    (indirect: By GRAT)
    22,100
  • Common Stock

    (indirect: By Trust)
    29,959
Footnotes (13)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2021.
  • [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $634.32 to $635.11, inclusive.
  • [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $635.45 to $636.40, inclusive.
  • [F12]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $636.57 to $637.11, inclusive.
  • [F13]The option vested in four equal installments on February 28, 2018, 2019, 2020, and 2021.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $625.98 to $626.915, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11) and (12) to this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $627.00 to $627.93, inclusive.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $628.05 to $628.96, inclusive.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $629.11 to $630.07, inclusive.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $630.19 to $631.14, inclusive.
  • [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $631.26 to $632.23, inclusive.
  • [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $632.29 to $633.27, inclusive.
  • [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $633.31 to $634.25, inclusive.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT